NCT00097045View on ClinicalTrials.gov

Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

December 31, 2006

Conditions
Hepatitis C
Interventions
DRUG

omega interferon

DRUG

Ribavirin

Trial Locations (3)

Unknown

Moscow

Saint Petersburg

Smolensk

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY